Guardant Health Stock Analysis

GH Stock  USD 37.11  1.00  2.62%   
Guardant Health is fairly valued with Real Value of 37.44 and Target Price of 53.0. The main objective of Guardant Health stock analysis is to determine its intrinsic value, which is an estimate of what Guardant Health is worth, separate from its market price. There are two main types of Guardant Health's stock analysis: fundamental analysis and technical analysis.
The Guardant Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Guardant Health's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Guardant Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.17. Guardant Health had not issued any dividends in recent years. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1373 people. To learn more about Guardant Health call Helmy Eltoukhy at 855 698 8887 or check out https://guardanthealth.com.

Guardant Health Quarterly Total Revenue

191.48 Million

Guardant Health Investment Alerts

Guardant Health appears to be risky and price may revert if volatility continues
The company generated the yearly revenue of 563.95 M. Annual Net Loss to common stockholders was (479.45 M) with gross profit of 293.21 M.
Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35.
Over 95.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Investors in Guardant Health from three years ago are still down 61, even after 8.6 percent gain this past week

Guardant Health Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Guardant Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Guardant Largest EPS Surprises

Earnings surprises can significantly impact Guardant Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-02-24
2019-12-31-0.31-0.270.0412 
2019-03-12
2018-12-31-0.35-0.30.0514 
2019-05-09
2019-03-31-0.37-0.30.0718 
View All Earnings Estimates

Guardant Health Environmental, Social, and Governance (ESG) Scores

Guardant Health's ESG score is a quantitative measure that evaluates Guardant Health's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Guardant Health's operations that may have significant financial implications and affect Guardant Health's stock price as well as guide investors towards more socially responsible investments.

Guardant Health Thematic Classifications

In addition to having Guardant Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare Idea
Healthcare
USA Equities from Healthcare industry as classified by Fama & French

Guardant Stock Institutional Investors

Shares
Geode Capital Management, Llc2024-09-30
2.8 M
Parkwood Llc2024-09-30
2.8 M
State Street Corp2024-09-30
2.8 M
Fuller & Thaler Asset Management Inc2024-09-30
2.2 M
Temasek Holdings Ltd.2024-09-30
2.1 M
Fidelity International Ltd2024-09-30
2.1 M
Morgan Stanley - Brokerage Accounts2024-09-30
1.7 M
Ark Investment Management Llc2024-09-30
1.5 M
Fmr Inc2024-09-30
1.5 M
Vanguard Group Inc2024-09-30
11.7 M
Blackrock Inc2024-06-30
11.2 M
Note, although Guardant Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Guardant Market Capitalization

The company currently falls under 'Mid-Cap' category with a market capitalization of 4.71 B.

Guardant Profitablity

The company has Net Profit Margin (PM) of (0.74) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.61) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.61.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.27)(0.28)
Return On Capital Employed(0.36)(0.38)
Return On Assets(0.27)(0.28)
Return On Equity(3.02)(3.17)

Management Efficiency

Guardant Health has Return on Asset (ROA) of (0.1608) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1608. This is way below average. Likewise, it shows a return on total equity (ROE) of (6.0928) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.28. The current Return On Capital Employed is estimated to decrease to -0.38. As of now, Guardant Health's Intangible Assets are increasing as compared to previous years. The Guardant Health's current Fixed Asset Turnover is estimated to increase to 2.51, while Total Assets are projected to decrease to under 1.4 B.
Last ReportedProjected for Next Year
Book Value Per Share 1.42  1.35 
Tangible Book Value Per Share 1.31  1.24 
Enterprise Value Over EBITDA(7.50)(7.87)
Price Book Value Ratio 19.09  13.78 
Enterprise Value Multiple(7.50)(7.87)
Price Fair Value 19.09  13.78 
Examining the leadership quality of Guardant Health offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Operating Margin
(0.61)
Profit Margin
(0.74)
Beta
1.106
Return On Assets
(0.16)
Return On Equity
(6.09)

Technical Drivers

As of the 6th of December, Guardant Health retains the risk adjusted performance of 0.1457, and Market Risk Adjusted Performance of 0.3775. Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Guardant Health Price Movement Analysis

The output start index for this execution was four with a total number of output elements of fifty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Guardant Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Guardant Health. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Guardant Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Guardant Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Guardant Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Guardant Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Guardant Health Outstanding Bonds

Guardant Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Guardant Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Guardant bonds can be classified according to their maturity, which is the date when Guardant Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Guardant Health Predictive Daily Indicators

Guardant Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Guardant Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Guardant Health Corporate Filings

F4
5th of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
3rd of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
2nd of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
19th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
18th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
14th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
13th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F4
12th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Guardant Health Forecast Models

Guardant Health's time-series forecasting models are one of many Guardant Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Guardant Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Guardant Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Guardant Health. By using and applying Guardant Stock analysis, traders can create a robust methodology for identifying Guardant entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.85)(0.89)
Operating Profit Margin(1.00)(1.05)
Net Loss(0.85)(0.89)
Gross Profit Margin 0.60  0.43 

Current Guardant Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Guardant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Guardant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
53.0Strong Buy22Odds
Guardant Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Guardant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Guardant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Guardant Health, talking to its executives and customers, or listening to Guardant conference calls.
Guardant Analyst Advice Details

Guardant Stock Analysis Indicators

Guardant Health stock analysis indicators help investors evaluate how Guardant Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Guardant Health shares will generate the highest return on investment. By understating and applying Guardant Health stock analysis, traders can identify Guardant Health position entry and exit signals to maximize returns.
Begin Period Cash Flow141.9 M
Long Term Debt1.1 B
Common Stock Shares Outstanding112 M
Total Stockholder Equity158.7 M
Tax Provision685 K
Property Plant And Equipment Net302.7 M
Cash And Short Term Investments1.2 B
Cash1.1 B
Accounts Payable51.7 M
Net Debt220.2 M
50 Day M A25.778
Total Current Liabilities205.9 M
Other Operating Expenses1.1 B
Non Current Assets Total439.3 M
Non Currrent Assets Other124.2 M
Stock Based Compensation90.8 M

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format